Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D With PEG-IFN/RBV in Egyptian Patients With Untreated Chronic Hepatitis C
NCT02099604Phase 3Withdrawn
- Sponsor
- ANRS
- Start
- Apr 2014
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in hepatitis C (HCV), sponsored by ANRS. Planned start Apr 2014; status: withdrawn.
02
Drugs
vitamin d
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02099604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099604.